Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study

By Choi Peter   Farouk Mourad   Manamley Nick   Addison Janet  

Advances in Therapy, Vol. 30, Iss. 11, 2013-11 ,pp. : 1007-1017

Springer Publishing Company

Access to resources Recommend Favorite

Dose Requirements among Hemodialysis Patients Treated with Darbepoetin-α or Epoetin-β

By  

Nephron Clin Pract, Vol. 107, Iss. 2, 2007-08 ,pp. : c50-c55

Karger

Access to resources Recommend Favorite

Impact of Switching From Darbepoetin Alfa to Epoetin Beta Pegol on Iron Utilization and Blood Pressure in Peritoneal Dialysis Patients

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 5, 2015-10 ,pp. : 450-456

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa

By Hymes Jeffrey   Bickimer Tammy   Jackson James H.   Bookhart Brahim K.   Mody Samir H.   Tak Piech Catherine  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1931-1937

Informa Healthcare

Access to resources Recommend Favorite

Erythropoietin-Alpha Dosage Requirements in a Provincial Hemodialysis Population: Effect of Switching from Subcutaneous to Intravenous Administration

By  

Nephron Clin Pract, Vol. 102, Iss. 3-4, 2005-11 ,pp. : c88-c92

Karger

Access to resources Recommend Favorite